Related Articles
Tumour MHC class I downregulation and immunotherapy (Review)
Immunization with MHC class I-negative but not -positive HPV16-associated tumour cells inhibits growth of MHC class I-negative tumours
Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate
NK1.1+ cells are important for the development of protective immunity against MHC I-deficient, HPV16-associated tumours